246
Views
7
CrossRef citations to date
0
Altmetric
Articles

In vitro model to assess the adsorption of oral veterinary drugs to mycotoxin binders in a feed- and aflatoxin B1-containing buffered matrix

, , ORCID Icon, &
Pages 1728-1738 | Received 15 Mar 2018, Accepted 29 Jun 2018, Published online: 06 Aug 2018

References

  • [EC] European Commission. 2002a. Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed. Off J Eur Communities L140. 45:10–21.
  • [EC] European Commission. 2002b. Commission Decision 2002/657/EC, implementing Council Directive 96/23/EC concerning the performances of analytical methods and interpretation of results. Off J Eur Communities L221. 45:8–36.
  • [EC] European Commission. 2006. Commission Recommendation No 2006/576/EC of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin A, T-2 and HT- 2 and fumonisins in products intended for animal feeding. Off J Eur Union, L229. 49:7–9.
  • [EC] European Commission. 2009. Commission Regulation No 386/2009 of 12 May 2009 amending Regulation (EC) No 1831/2003 of the European Parliament and of the Council as regards the establishment of a new functional group of feed additives. Off J Eur Union L118. 52:66.
  • [EC] European Commission. 2013a. Commission Recommendation No 2013/165/EU of 27 March 2013 on the presence of T-2 and HT-2 toxin in cereals and cereal products. Off J Eur Union L91. 56:12–15.
  • [EC] European Commission. 2013b. Commission Implementing Regulation (EU) No 1060/2013 of 29 October 2013 concerning the authorisation of bentonite as a feed additive for all animal species. Off J Eur Communities L289. 56:33–37.
  • [EC] European Commission. 2018. European union register of feed additives pursuant to regulation (EC) No 1831/2003 Appendixes 3e & 4(I). Annex I: list of additives. Off J Eur Communities. 8:1693. https://ec.europa.eu/food/sites/food/files/safety/docs/animal-feed-eu-reg-comm_register_feed_additives_1831-03.pdf.
  • [EFSA] European Food Safety Authority. 2009. Review of mycotoxin-detoxifying agents used as feed additives: mode of action, efficacy and feed/food safety. http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/22e.pdf.
  • Avantaggiato G, Havenaar R, Visconti A. 2003. Assessing the zearalenone-binding activity of adsorbent materials during passage through a dynamic in vitro gastrointestinal model. Food Chem Toxicol. 41:1283–1290.
  • Baert K, Croubels S, Gasthuys F, De Busser J, De Backer P. 2000. Pharmacokinetics and oral bioavailability of a doxycycline formulation (DOXYCYCLINE 75%) in nonfasted young pigs. J Vet Pharmacol Ther. 23(1):45–48.
  • Blanquet S, Zeijdner E, Beyssac E, Meunier JP, Denis S, Havenaar R, Alric M. 2004. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharmaceuyical Res. 21:585–591.
  • De Baere S, Goossens J, Osselaere A, Devreese M, Vandenbroucke V, De Backer P, Croubels S. 2011. Quantitative determination of T-2 toxin, HT-2 toxin, deoxynivalenol and deepoxy-deoxynivalenol in animal body fluids using LC-MS/MS detection. J Chromatogr B. 879:2403–2415.
  • De Mil T, Devreese M, Broekaert N, Fraeyman S, De Backer P, Croubels S. 2015b. In vitro adsorption and in vivo pharmacokinetic interaction between doxycycline and frequently used mycotoxin binders in broiler chickens. J Agric Food Chem. 63:4370–4375.
  • De Mil T, Devreese M, De Baere S, Van Ranst E, Eeckhout M, De Backer P, Croubels S. 2015a. Characterization of 27 mycotoxin binders and the relation with in vitro zearalenone adsorption at a single concentration. Toxins. 7:21–33.
  • De Mil T, Devreese M, Maes A, De Saeger S, De Backer P, Croubels S. 2017. Influence of mycotoxin binders on the oral bioavailability of tylosin, doxycycline, diclazuril and salinomycin in fed broiler chickens. Poult Sci. 96:2137–2144.
  • Del Castillo JRE. 2013. Tetracyclines. In: Giguère S, Prescott JF, Dowling PM, editors. Antimicrobial therapy in veterinary medicine. Hoboken (NJ): John Wiley & Sons, Inc; p. 257–268.
  • Deng YJ, Velazquez ALB, Billes F, Dixon JB. 2010. Bonding mechanisms between aflatoxin B-1 and smectite. Appl Clay Sci. 50:92–98.
  • Devreese M, Osselaere A, Goossens J, Vandenbroucke V, De Baere S, De Backer P, Croubels S. 2012. Interaction between tylosin and bentonite clay from a pharmacokinetic perspective. Vet J. 194:437–439.
  • Devreese M, Pasmans F, De Backer P, Croubels S. 2013. An in vitro model using the IPEC-J2 cell line for efficacy and drug interaction testing of mycotoxin detoxifying agents. Toxicol Vitro. 27:157–163.
  • Faucet-Marquis V, Joannis-Cassan C, Hadjeba-Medjdoub K, Ballet N, Pfohl-Leszkowicz A. 2014. Development of an in vitro method for the prediction of mycotoxin binding on yeast-based products: case of aflatoxin B-1, zearalenone and ochratoxin A. Appl Microbiol Biotechnol. 98:7583–7596.
  • Joannis-Cassan C, Tozlovanu M, Hadjeba-Medjdoub K, Ballet N, Pfohl-Leszkowicz A. 2011. Binding of zearalenone, aflatoxin B-1 and ochratoxin A by yeast-based products: a method for quantification of adsorption performance. J Food Prot. 74:1175–1185.
  • Marasanapalle VP, Li X, Jasti BR. 2011. Effects of food on drug absorption. In: Hu M, Li X, editors. Oral bioavailability. Basic principles, advanced concepts, and applications. Hoboken (NJ): John Wiley & Sons, Inc; p. 221–231.
  • Maresca M. 2013. From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol. Toxins. 5:784–820.
  • Matuszewski BK, Constanzer ML, Chavez-Eng CM. 2003. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 75:3019–3030.
  • Monbaliu S, Van Poucke C, Detavernier C, Dumoulin F, Van de Velde M, Van Dyck S, Averkieva O, Van Peteghem C, De Saeger S. 2009. A multi-mycotoxin LC-MS/MS method for feed analysis. J Vet Pharmacol Ther. 32:99.
  • Paesen J, Cypers W, Pauwels K, Roets E, Hoogmartens J. 1995. Study of the stability of tylosin-A in aqueous-solutions. J Pharm Biomed Anal. 13:1153–1159.
  • Pesti GM, Amato SV, Minear LR. 1985. Water consumption of broiler chickens under commercial conditions. Poult Sci. 64:803–808.
  • Ramos AJ, Hernandez E, PlaDelfina JM, Merino M. 1996. Intestinal absorption of zearalenone and in vitro study of non-nutritive sorbent materials. Int J Pharm. 128:129–137.
  • Sabater-Vilar M, Malekinejad H, Selman MHJ, van der Doelen MAM, Fink-Gremmels J. 2007. In vitro assessment of adsorbents aiming to prevent deoxynivalenol and zearalenone mycotoxicoses. Mycopathologia. 163:81–90.
  • Shryock TR, Klink PR, Readnour RS, Tonkinson LV. 1994. Effect of bentonite incorporated in a feed ration with tilmicosin in the prevention of induced Mycoplasma gallisepticum airsacculitis in broiler chickens. Avian Dis. 38:501–505.
  • Vekiru E, Fruhauf S, Sahin M, Ottner F, Schatzmayr G, Krska R. 2007. Investigation of various adsorbents for their ability to bind Aflatoxin B1. Mycotoxin Res. 23:27–33.
  • [VICH] International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. 2015. VICH GL 49 (R) - Metabolism and Residue Kinetics. Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: validation of analytical methods used in residue depletion studies, revision at step 9 for implementation at step 7. https://www.vichsec.org/guidelines/pharmaceuticals/pharma-safety/metabolism-and-residue-kinetics.html.
  • Weng ND, Sun H, Roets E, Busson R, Hoogmartens J. 1993. Investigation of Keto-Enol-Tautomerism and ionization of doxycycline in aqueous-solutions. Int J Pharm. 96:13–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.